NASDAQ · Drug Manufacturers - Specialty & Generic

Cardiol Therapeutics Inc. (CRDL) Stock

$1.23 -5.38% NASDAQ: CRDL Healthcare

Valuation

MetricValue
Price$1.23
Market Cap$141.78M
P/E Ratio-5.90
P/B Ratio9.71
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$2.34
52-Week Low$0.88
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-180.13%
ROA-116.08%
ROCE-148.81%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio4.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-31.0M$-30.0M$-22.0M$-40.0M$-34.0M
Net Profit$-25.0M$-23.0M$-21.0M$-37.0M$-34.0M
EPS$-0.73$-0.49$-0.44$-0.51$-0.39
Op Margin-49092.4%————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$88.0M$46.0M$37.0M$32.0M$24.0M
Total Liabilities$12.0M$7.0M$8.0M$7.0M$6.0M
Cash$84.0M$44.0M$35.0M$31.0M$21.0M
Borrowings$0$0$0$0$0

Latest News

Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association CNW Group · Jul 14, 2026 Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit PR Newswire · Jul 9, 2026 Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders PR Newswire · Jun 25, 2026 Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT CNW Group · Jun 23, 2026 Here's Why We're Watching Cardiol Therapeutics' (TSE:CRDL) Cash Burn Situation Simply Wall St. · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-24.0M$-27.0M$-25.0M$-25.0M$-24.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$9.0M$0$0$-2.0M$0
Net Cash Flow$70.0M$-24.0M$-25.0M$-4.0M$-9.0M
Free Cash Flow$-24.0M$-27.0M$-25.0M$-25.0M$-24.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.16
EV / EBITDA-5.85
FCF Yield-10.30%
Quick Ratio5.55
Interest Coverage0.00
Return 1Y-13.53%
Return 3Y41.28%
Return 5Y-48.20%

Ownership

Insiders Held2.38%
Institutions Held24.67%
Institutions Float Held25.27%
Institutional HolderSharesReport Date
MMCAP International, Inc. SPC15,352,3172026-03-31
Tejara Capital Ltd5,130,1222026-03-31
Ikarian Capital, LLC2,725,0002026-03-31
Citadel Advisors Llc819,9042026-03-31
Boothbay Fund Management, LLC794,8812026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ASRT $23.44 +0.30% -4.95 $151.47M 0.00%
CNTBConnect Biopharma Holdings Limited $0.87 -1.21% -1.05 $54.78M 0.00%
HYPRHyperfine, Inc. $0.93 -1.00% -2.33 $78.38M 0.00%
IFRXInflaRx N.V. $1.60 +4.58% -3.14 $235.67M 0.00%
IMAImageneBio, Inc. $4.24 -0.47% -0.87 $47.82M 0.00%

About Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc. is led by CEO David G. Elsley, employs 18 people, headquartered in CA, publicly traded since 2019.

Cardiol Therapeutics Inc. (CRDL) stock trades at $1.23 with a market capitalization of $141.78M. The stock is valued at a price-to-earnings (P/E) ratio of -5.90, price-to-book of 9.71, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.88 and $2.34, and currently trades 47.4% below its 52-week high.

On profitability, Cardiol Therapeutics Inc. generates a return on equity (ROE) of -180.13%, return on capital employed of -148.81%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides